Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide or Semaglutide vs Conventional Treatment on Gut Microbiota in Japanese Patients With Type 2 Diabetes
jRCT1051240017Recruiting
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of tirzepatide and semaglutide in type 2 diabetes mellitus (T2DM) (3 arms). Started May 2024; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1051240017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240017.